
Tardive Dyskinesia Treatment | AUSTEDO XR® (deutetrabenazine)
See Important Safety Information, including Boxed Warning. How AUSTEDO XR® (deutetrabenazine) extended-release tablets may help.
Austedo (deutetrabenazine): Uses, Side Effects, Dosage Guide
Aug 20, 2025 · Austedo is used to treat the involuntary movements of Huntington's disease and tardive dyskinesia (TD). Includes Austedo side effects, dosage, uses, interactions, and more
Tardive Dyskinesia (TD) | AUSTEDO XR® (deutetrabenazine) extended ...
See Prescribing Information, including Boxed Warning. Find information for healthcare professionals about once-daily AUSTEDO XR.
Tardive Dyskinesia: Symptoms, Causes, Treatment, and More
Jan 29, 2026 · Tardive dyskinesia is a side effect caused by neuroleptic drugs. Learn more about why this happens and a list of medications commonly linked with tardive dyskinesia.
Austedo (deutetrabenazine): Uses, Side Effects, Interactions ... - WebMD
Jun 26, 2024 · Find patient medical information for Austedo (deutetrabenazine) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings
FDA Approves One Pill, Once-Daily Tablets of ... - Neurology live
May 30, 2024 · The FDA has approved a new one-pill, once-daily tablet administration option for deutetrabenazine (Austedo XR; Teva Pharmaceuticals), a medication for tardive dyskinesia and …
Austedo Phase 4 Data Shows Reduction in Tardive Dyskinesia Severity
Nov 12, 2025 · New phase 4 data reveals Austedo significantly reduces involuntary movements and enhances quality of life for adults with tardive dyskinesia.
Austedo (deutetrabenazine): Uses, Side Effects, Dosage & More - GoodRx
Jun 17, 2025 · Learn about Austedo (deutetrabenazine) usage and dosing. Read the latest news and reviews about the drug as well as potential side effects and popular alternatives.
Tardive Dyskinesia Distinguishing From Drug Induced Disorders
Feb 6, 2026 · Antipsychotic-induced-movement-disorders-can-mimic-tardive-dyskinesia-mdash-learn-key-differences-symptoms-and-diagnostic-clues-for-accurate-treatment
Lactation Risk Summary: There are no data on the presence of deutetrabenazine or its metabolites in human milk, the effects on the breastfed infant, or the effects of the drug on milk production. The …